IN-DATE
0118L18: Bard Bardex Lubricath Two-Way 18F Foley Catheter, 30cc Balloon
Sign in to add this product to your favorites!
| Price: | $149.00 per box of 12 |
|---|---|
| Quantity: | |
| In Stock: | 2 box of 12 |
| Expiration: | 03-2027 |
Additional Details
BD Bard Bardex® Lubricath® Foley Catheters
The BARDEX® LUBRICATH® latex Foley catheter provides for smoother insertion and enhanced patient comfort through the hydrogel coating's unique ability to absorb fluid, thus creating a hydrophilic "cushion" between the catheter surface and the urethra.
Product Code: 0118L18
- 2-Way
- Balloon 30cc, 18F
- Lubricath™, 2-Way, Specialty, Short Round Tip, Two Opposing Drainage Eyes
AccessGUDID Info
- FDA Product Code: KOD
- FDA Product Code Name: CATHETER, UROLOGICAL
- GMDN Term Code: 34917
- GMDN Term Name: Indwelling urethral drainage balloon catheter, non-antimicrobial
- GMDN Term Description: A flexible tube with an inflatable balloon at its distal tip intended to be inserted through the urethra and retained in the urinary bladder, or prostatic bed, of an adult or paediatric patient to function as an indwelling therapeutic device for urinary drainage; it might also be designed for infusion of fluids (irrigation). It may have a bent tip (coude) to facilitate insertion, and some types may be provided with a guidewire to facilitate difficult insertion (e.g., in cases of enlarged prostate); it does not include an antimicrobial agent(s). Most types are commonly known as a Foley catheter; it is intended to be introduced by a healthcare professional. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
